gender identity disorder: A disorder characterized by a strong and persistent cross-gender identification (such as stating a desire to be the other sex or frequently passing as the other sex) coupled with persistent discomfort with his or her sex (manifested in adults, for example, as a preoccupation with altering primary and secondary sex characteristics through hormonal manipulation or surgery).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
527 |
4. Check minimum number of eventsNone |
527 |
5. Include endpointsNone |
527 |
6. Filter based on genotype QC (FinnGen only) |
527 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F63-F69
- Name in latin
- Perturbationes identitatis generis
Similar endpoints
↥List of similar endpoints to
Gender identity disorders
based on the number of shared cases.
Similar with more cases:
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5826 | 3422 | 2338 |
| Only index persons | 5682 | 3391 | 2291 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 22.20 | 20.84 | 23.99 |
| Only index persons | 22.03 | 20.81 | 23.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 527 | 358 | 169 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.07 |
| Median age at first event (years) | 25.59 | 23.39 | 30.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 453
- Matched controls
- 4530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
+∞
323.0
437
*
F64.0
ICD-10 Finland
Transsexualism
+∞
323.0
281
*
IBZ08
NOMESCO Finland
Gender identity assessment
+∞
318.8
267
*
ZY010
NOMESCO Finland
Hospital outpatient
24.4
153.1
235
191
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
57.9
120.6
141
35
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
18.3
120.6
204
194
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
18.8
92.2
149
115
121
Kela drug reimbursment
Severe hypofunction of sexual glands
71.8
81.6
92
16
Z3231
NOMESCO Finland
Registered nurse
7.1
74.8
239
618
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
13.3
71.6
134
139
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
+∞
69.6
65
*
Z2445
NOMESCO Finland
Psychologist
11.1
69.0
143
181
F64.8
ICD-10 Finland
Other gender identity disorders
687.0
62.4
60
*
ZYC01
NOMESCO Finland
Remote contact by phone
13.6
60.5
110
104
N05AH04
ATC
quetiapine; oral
6.2
58.8
193
481
ZYC02
NOMESCO Finland
Remote contact by video link
634.4
58.0
56
*
G03HA01
ATC
cyproterone; systemic
312.7
55.5
55
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
17.9
55.0
88
60
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
15.6
51.4
87
68
Z2221
NOMESCO Finland
Medical doctor
5.2
51.1
203
612
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.7
50.7
177
460
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
7.5
46.1
119
204
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
48.8
43.3
52
12
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
9.5
41.2
89
113
Z2446
NOMESCO Finland
Social worker
7.2
39.2
103
178
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
47.4
35.7
43
10
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
195.0
35.3
36
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
8.0
34.9
84
126
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
12.9
34.8
63
56
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
7.8
34.3
84
129
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
13.1
33.5
60
52
N06AX16
ATC
venlafaxine; oral
5.1
33.3
119
297
N06AX12
ATC
bupropion; oral
6.1
31.2
92
182
N06AB10
ATC
escitalopram; oral
3.7
31.2
173
649
N06AB03
ATC
fluoxetine; oral
5.3
31.2
105
244
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
18.4
30.9
48
29
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.9
30.9
94
193
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
7.3
30.7
78
126
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
322.9
30.2
30
*
N06AX11
ATC
mirtazapine; oral
3.6
30.0
169
638
N06AB06
ATC
sertraline; oral
4.8
30.0
111
285
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
9.1
29.9
65
82
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.5
29.5
119
333
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
10.5
28.1
56
60
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
287.2
27.0
27
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
6.2
27.0
77
145
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.0
26.8
69
113
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
7.4
25.8
64
99
F84.5
ICD-10 Finland
Asperger syndrome
16.8
25.1
40
26
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.8
24.9
59
85
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
24.9
138
502
F61.0
ICD-10 Finland
Mixed personality disorders
71.5
24.1
27
*
W78
ICPC
Pregnancy
0.1
24.0
13
880
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.6
23.9
64
110
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.1
23.9
14
897
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.0
23.6
68
129
F32.1
ICD-10 Finland
Moderate depressive episode
4.7
23.4
85
210
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
23.6
23.4
33
15
P09
ICPC
Sexual preference concern
+∞
23.1
22
*
SPAT1379
SPAT
Health check-up of pregnant person
0.1
22.7
6
701
ZYY01
NOMESCO Finland
Contact between professionals
47.7
22.6
27
6
N05AX12
ATC
aripiprazole; systemic
6.6
22.6
60
102
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
14.8
22.2
37
27
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
52.7
21.3
25
5
N05AX08
ATC
risperidone; systemic
6.0
21.0
60
112
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.4
20.8
116
415
F40.1
ICD-10 Finland
Social phobias
6.1
20.8
59
109
C03DA01
ATC
spironolactone; oral
7.8
20.1
47
66
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.1
20.1
10
729
N05BA04
ATC
oxazepam; oral
3.2
19.9
121
461
N05AH03
ATC
olanzapine; systemic
5.6
19.9
60
120
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
30.5
19.9
26
9
ZZA50
NOMESCO Finland
Full thickness skin graft
208.7
19.7
20
*
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
12.5
19.6
35
30
SPAT1197
SPAT
Extensive health check-up of expecting family
0.1
19.6
11
734
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
33.0
19.5
25
8
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.1
19.1
126
505
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
57.6
19.1
22
*
N03AX09
ATC
lamotrigine; oral
5.8
18.9
55
105
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.6
18.7
56
111
SPAT1380
SPAT
Postpartum check-up
0.1
18.5
5
578
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.1
18.2
7
618
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
15.6
17.4
28
19
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.9
16.9
48
89
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
16.9
149
708
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.1
16.9
7
585
F64
ICD-10 Finland
Gender identity disorders
+∞
16.8
16
*
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.0
16.6
*
391
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.2
16.5
65
172
P76
ICPC
Depressive disorder
3.8
16.5
75
226
G03DC03
ATC
lynestrenol; oral
9.5
16.2
33
37
SPAT1240
SPAT
Therapeutic discussion
2.8
16.0
121
524
P03
ICPC
Feeling depressed
2.7
15.9
126
560
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
+∞
15.7
15
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.1
15.7
10
622
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.2
15.5
42
73
SPAT1243
SPAT
Psychiatric/psychological examination
4.6
15.3
55
133
N06AB04
ATC
citalopram; systemic
3.2
15.0
85
303
W11
ICPC
Contraception oral
0.3
15.0
51
1245
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.2
14.9
47
99
F93.89
ICD-10 Finland
Other childhood emotional disorders
6.4
14.7
39
66
P29
ICPC
Psychological sympt/compl other
3.4
14.6
77
260
N06AX26
ATC
vortioxetine; oral
3.9
14.6
62
176
N06BA04
ATC
methylphenidate; oral
4.3
14.2
54
138
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
8.0
13.9
31
41
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.0
13.8
38
68
Z32.1
ICD-10 Finland
Pregnancy confirmed
0.1
13.7
*
441
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
13.7
111
494
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
26.7
13.5
18
7
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.4
13.2
68
226
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
29.3
13.0
17
6
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
9.4
12.9
26
29
P01
ICPC
Feeling anxious/nervous/tense
2.2
12.9
161
893
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.2
12.8
11
567
SPAT1389
SPAT
Visit based on need for special support
3.3
12.5
65
217
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.4
12.1
36
71
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.6
12.1
35
67
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.0
12.0
33
59
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.1
11.9
37
77
F32
ICD-10 Finland
Depressive episode
3.7
11.7
52
153
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
0.1
11.5
6
431
P74
ICPC
Anxiety disorder/anxiety state
3.4
11.4
58
190
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
17.6
11.3
17
10
F34.1
ICD-10 Finland
Dysthymia
5.4
11.2
33
65
IEY01
NOMESCO Finland
Psychoeducation, individual
10.0
10.9
21
22
DQW99
NOMESCO Finland
Other operation on larynx
+∞
10.5
10
*
F60.8
ICD-10 Finland
Other specific personality disorders
33.4
10.4
13
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.2
10.3
10
479
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
0.1
10.3
*
333
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.1
10.2
5
378
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
10.1
52
172
WX402
NOMESCO Finland
General anaesthesia
2.5
10.1
83
368
N05CF01
ATC
zopiclone; oral
2.6
10.0
75
317
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
12.6
9.9
17
14
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
20.6
9.9
14
7
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
9.8
25
41
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
7.1
9.7
23
34
N06AX05
ATC
trazodone; oral
8.7
9.7
20
24
Z3226
NOMESCO Finland
Physiotherapist
2.6
9.6
75
325
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.5
9.5
33
78
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.7
9.5
41
119
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.7
9.3
31
70
F31.8
ICD-10 Finland
Other bipolar affective disorders
5.8
9.2
25
45
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.1
8.9
*
278
N05AF03
ATC
chlorprothixene; systemic
8.9
8.9
18
21
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
14.4
8.7
14
10
N06AX22
ATC
agomelatine; oral
5.7
8.7
24
44
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.6
8.7
29
66
F60.9
ICD-10 Finland
Personality disorder, unspecified
51.0
8.7
10
*
MAX99
NOMESCO Finland
Assistance to normal delivery
0.1
8.6
5
340
ZXY03
NOMESCO Finland
Occupational therapist
16.7
8.6
13
8
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.6
8.6
29
67
R49.08
ICD-10 Finland
Other specified dysphonia
10.3
8.6
16
16
P99
ICPC
Psychological disorders other
4.4
8.6
30
72
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.2
8.5
25
50
F33.8
ICD-10 Finland
Other recurrent depressive disorders
11.0
8.3
15
14
N06AX21
ATC
duloxetine; oral
3.1
8.2
43
146
MA3AE
NOMESCO Finland
Combined first trimester screening
0.1
8.2
*
279
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
10.3
8.1
15
15
N05AD01
ATC
haloperidol; systemic
11.1
7.8
14
13
N06AB05
ATC
paroxetine; oral
4.1
7.7
29
75
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.7
7.7
25
56
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.4
7.7
36
796
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
25.5
7.6
10
*
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
0.4
7.6
29
697
N05AN01
ATC
lithium; oral
7.3
7.5
17
24
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
0.2
7.5
5
304
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.1
7.5
19
32
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.0
7.5
*
215
HAC99
NOMESCO Finland
Other mastectomy
81.4
7.4
8
*
SPAT1284
SPAT
Extensive health certificate
3.6
7.4
32
94
IDY25
NOMESCO Finland
Systematic individual therapy, visual arts psychotherapy
+∞
7.3
7
*
F33
ICD-10 Finland
Recurrent depressive disorder
4.8
7.3
23
50
Z37.0
ICD-10 Finland
Single live birth
0.2
7.3
5
302
N05BA01
ATC
diazepam; systemic, rectal
2.8
7.2
45
169
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.1
7.2
38
130
N03AX16
ATC
pregabalin; oral
2.5
7.2
56
243
W90
ICPC
Uncompl labour/delivery livebirth
0.1
7.2
*
230
SPAT1241
SPAT
Extensive assessment of psychosocial situation
4.9
7.1
22
47
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.1
7.1
*
252
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.1
7.1
*
276
N05AE04
ATC
ziprasidone; systemic
10.3
7.1
13
13
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
7.2
7.1
16
23
R4120
NOMESCO Finland
Occupational therapy
3.9
7.0
27
72
HA1AA
NOMESCO Finland
X-ray mammography
5.6
7.0
19
35
F50.0
ICD-10 Finland
Anorexia nervosa
5.2
6.9
20
40
N05AB03
ATC
perphenazine; systemic, rectal
5.5
6.8
19
36
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.3
6.8
32
101
P80
ICPC
Personality disorder
40.7
6.8
8
*
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.2
6.7
8
343
O80.8
ICD-10 Finland
Other single spontaneous delivery
0.0
6.6
*
192
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.5
6.5
29
88
P86
ICPC
Anorexia nervosa/bulimia
7.6
6.5
14
19
ZXY61
NOMESCO Finland
2-person team, special workers
14.6
6.4
10
7
N03AG01
ATC
valproic acid; systemic, rectal
3.4
6.4
29
89
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.3
6.4
13
16
HAC20
NOMESCO Finland
Total mastectomy
9.4
6.3
12
13
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
18.3
6.3
9
5
RT250
NOMESCO Finland
NA
27.1
6.2
8
*
IGP01
NOMESCO Finland
Psychiatric family contact
5.5
6.2
17
32
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.5
6.1
20
46
IBA03
NOMESCO Finland
Psychotherapy evaluation
5.0
6.1
18
37
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
10.2
6.1
11
11
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
0.1
6.0
*
178
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017446) Testosterone [Moles/volume] in Serum or Plasma
165
307
7.37
91.00
2.4
1.9
nmol/l
11.0
11.8
0.32
144
279
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
98
129
9.10
72.53
2.2
1.7
nmol/l
0.3
0.4
0.95
89
114
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
309
4303
0.32
34.78
3.3
4.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
120
381
3.78
32.58
1.9
1.6
mu/l
349.7
301.6
1.30
112
337
(3009214) Lutropin [Units/volume] in Serum or Plasma
86
269
3.63
23.45
2.0
1.5
u/l
5.7
8.4
2.66
70
220
(3023323) Follitropin [Units/volume] in Serum or Plasma
78
260
3.35
19.12
2.1
1.4
iu/l
4.6
13.0
7.16
65
204
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
899
0.10
18.43
1.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
73
248
3.26
17.30
2.2
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
568
0.10
16.79
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
65
1553
0.34
16.02
1.8
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
139
690
2.38
15.76
1.6
1.5
mmol/l
1.4
1.3
0.51
123
622
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
141
726
2.29
14.56
1.8
1.6
%
1.5
1.3
2.23
130
663
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
479
0.12
13.30
1.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
187
2770
0.50
12.97
2.8
3.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
93
426
2.44
12.39
2.9
2.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
422
0.11
11.89
1.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
422
0.11
11.89
1.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
422
0.11
11.89
1.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
421
0.11
11.88
1.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
87
1658
0.43
11.86
1.4
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
390
0.12
10.65
1.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
128
2040
0.51
10.03
2.4
2.9
estimate
0.0
0.0
0.00
31
444
(46235355) HIV 1 and 2 tests - Meaningful Use set
142
2178
0.52
9.75
1.8
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
129
2024
0.52
9.42
2.3
2.8
estimate
0.0
0.0
0.00
29
445
(3021601) Nitrite [Presence] in Urine by Test strip
129
2018
0.52
9.29
3.1
3.9
estimate
0.0
0.0
0.50
33
459
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
395
3220
1.91
9.28
3.7
3.6
pmol/l
14.5
14.4
0.21
357
2894
(21494755) Public health laboratory ask at order entry panel
19
677
0.25
9.12
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
332
0.14
8.41
1.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
107
1722
0.52
8.12
1.5
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
364
4205
0.57
7.89
7.4
8.8
mg/l
16.2
20.8
2.24
210
3118
(3001122) Ferritin [Mass/volume] in Serum or Plasma
168
2357
0.58
7.73
2.3
2.7
ug/l
49.8
57.4
0.97
146
2211
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
68
1241
0.48
7.47
2.0
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
135
1986
0.57
7.27
1.9
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
98
1576
0.54
7.20
2.4
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
57
1090
0.47
7.09
1.4
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
284
0.17
6.58
2.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
125
1840
0.58
6.53
1.9
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
74
1265
0.52
6.51
2.2
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
1009
0.47
6.43
1.1
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
460
4920
0.49
6.37
12.2
12.3
g/l
138.9
136.5
3.27
443
4851
(3010813) Leukocytes [#/volume] in Blood
460
4919
0.49
6.32
12.1
12.3
e9/l
6.7
6.8
0.03
412
4792
(3026361) Erythrocytes [#/volume] in Blood
460
4916
0.49
6.17
12.1
12.2
e12/l
4.7
4.6
2.56
415
4790
(3024731) MCV [Entitic volume]
460
4915
0.50
6.12
12.1
12.2
fl
88.8
88.8
0.09
445
4846
(3035941) MCH [Entitic mass]
460
4913
0.50
6.03
12.0
12.2
pg
29.6
29.8
0.91
445
4843
(3015377) Calcium [Moles/volume] in Serum or Plasma
132
871
1.69
5.95
2.1
2.4
mmol/l
2.4
2.4
0.12
119
780
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
1030
0.50
5.88
1.9
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
460
4906
0.51
5.71
12.1
12.3
e9/l
269.8
261.2
1.47
415
4777
(4198724)
17
46
3.79
5.69
1.4
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
85
503
1.82
5.58
2.3
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
129
1826
0.61
5.50
1.7
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
698
0.44
5.24
1.6
2.3
u/l
254.4
5497.2
—
6
266
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
87
2.84
5.11
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
290
0.26
4.97
2.1
2.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
13
32
4.14
4.92
2.8
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
163
1184
1.55
4.83
3.6
2.6
u/l
29.9
28.1
0.44
147
1121
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
522
0.40
4.62
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
124
2.42
4.49
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
415
4511
0.62
4.44
7.6
7.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
362
4047
0.66
4.39
9.9
9.9
g/l
333.0
334.2
1.64
356
4007
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
26
4.30
4.37
1.4
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
26
4.30
4.37
2.7
6.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
99
656
1.63
4.30
2.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
99
662
1.61
4.14
2.2
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
92
607
1.62
4.06
2.3
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
98
660
1.60
3.97
2.2
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
848
0.56
3.87
2.6
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
498
0.44
3.86
1.7
2.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
483
0.43
3.83
1.7
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
72
1091
0.61
3.82
1.8
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
138
1808
0.68
3.69
3.2
4.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
96
655
1.57
3.67
2.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
373
0.38
3.52
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
6
10.10
3.50
5.0
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
119
863
1.49
3.43
2.5
3.0
mmol/l
9.1
9.1
0.01
94
772
(3022621) pH of Urine by Test strip
7
224
0.30
3.41
1.6
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
1087
0.63
3.40
2.1
2.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
60
380
1.65
3.11
2.6
2.3
mmol/l
2.4
2.4
0.23
52
333
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
825
0.60
3.10
2.1
1.9
—
—
—
0
0
(3015736) pH of Urine
120
1570
0.69
3.06
2.3
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
77
1097
0.65
3.05
2.6
3.0
estimate
0.0
0.0
1.08
30
442
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
313
2742
1.35
2.83
3.3
3.2
mmol/mol
34.7
36.3
2.85
293
2601
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
410
3751
1.42
2.82
4.6
4.1
mu/l
1.9
1.8
1.30
383
3535
(3018095) Leukocytes [#/volume] in Urine
96
1288
0.69
2.78
2.8
3.1
e6/l
31.0
107.5
1.60
61
803
(40760892) CBC W Ordered Manual Differential panel - Blood
76
1065
0.67
2.76
5.1
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
281
1.70
2.75
2.2
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
406
4346
0.71
2.61
8.8
8.8
%
41.9
40.7
7.29
313
3706
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
69
974
0.66
2.58
1.9
2.0
mg/l
2.9
2.6
0.38
50
834
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
6
11
5.50
2.55
1.0
2.4
nmol/l
1.5
2.2
—
6
11
(3023368) Bacteria identified in Blood by Culture
41
647
0.60
2.53
5.3
3.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
774
0.64
2.50
1.7
1.8
mg/l
0.5
0.8
1.98
33
514
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
68
476
1.49
2.33
1.3
1.4
pmol/l
446.6
15438210.4
0.50
49
434
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
8
23
3.52
2.27
1.0
1.9
nmol/l
7.3
7.7
—
8
23
(1761868) Lipid panel - Serum or Plasma
114
1428
0.74
2.10
2.1
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
50
336
1.54
2.08
1.6
1.6
nmol/l
1124.6
1134.3
0.02
35
259
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
26
437
0.57
2.07
1.5
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
145
0.34
2.04
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
229
0.43
2.01
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
209
1790
1.28
2.00
6.8
7.3
e9/l
0.0
0.0
0.48
162
1457
(3024561) Albumin [Mass/volume] in Serum or Plasma
137
1111
1.32
1.98
3.4
4.6
g/l
38.5
38.3
0.17
118
1034
(1761482) Bacteria [#/volume] in Urine by Culture
0
53
0.00
1.88
0.0
2.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
53
0.00
1.88
0.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
63
848
0.71
1.82
2.4
2.3
ng/l
45.6
22.1
0.32
22
302
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
47
0.00
1.71
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
190
0.46
1.64
1.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
101
1245
0.77
1.62
2.0
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
14
3.59
1.62
7.0
7.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
369
0.61
1.56
1.3
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
6
142
0.42
1.54
1.8
2.2
e6/l
0.2
0.2
—
6
133
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
181
0.49
1.53
1.3
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
43
0.00
1.53
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
44
0.00
1.52
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
167
0.47
1.49
1.3
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
481
0.67
1.47
1.1
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
28
2.52
1.45
1.4
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
7
154
0.45
1.45
11.1
14.1
g/l
117.0
125.8
—
7
145
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
88
1087
0.77
1.43
2.6
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
966
0.76
1.40
2.2
2.4
u/l
54.2
56.0
0.18
64
892
(3018418) pH of Serum or Plasma
89
714
1.30
1.39
2.4
3.2
ph
7.4
7.4
0.21
17
141
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
368
3445
1.23
1.35
3.2
2.7
mmol/l
2.8
2.7
1.14
338
3245
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
37
0.00
1.35
0.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
202
2256
0.83
1.28
7.8
7.2
e9/l
3.9
3.9
0.08
170
1974
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
420
0.67
1.28
1.2
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
165
1877
0.82
1.27
4.8
5.8
%
8.2
8.0
0.53
148
1776
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
364
3415
1.21
1.25
3.1
2.6
mmol/l
1.3
1.4
9.65
336
3236
(3026493) Urate [Moles/volume] in Serum or Plasma
44
588
0.73
1.24
1.8
2.4
umol/l
340.7
4450.6
1.78
37
539
(3002582) Erythrocytes [#/volume] in Urine
80
981
0.78
1.23
2.3
2.7
e6/l
24.3
77.5
1.05
57
729
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
366
3439
1.21
1.23
3.2
2.7
mmol/l
4.5
4.5
0.75
338
3265
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
141
0.49
1.22
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
57
1.95
1.17
1.1
3.5
nmol/l
1.0
1.0
0.06
11
52
(3000093) Morphology [Interpretation] in Blood Narrative
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
33
0.00
1.16
0.0
17.9
—
105.2
—
0
25
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
163
1429
1.20
1.16
2.2
2.2
nmol/l
58.1
68.4
5.45
141
1330
(3040151) Glucose [Moles/volume] in Capillary blood
0
35
0.00
1.15
0.0
2.7
—
5.6
—
0
27
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
502
0.72
1.15
2.2
2.3
e6/l
1.0
1.3
0.43
19
252
(3032080) INR in Blood by Coagulation assay
73
895
0.79
1.12
4.3
5.1
inr
1.0
1.1
0.41
43
346
(3041806) Other cells [#/volume] in Blood by Manual count
17
104
1.66
1.10
1.3
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
163
0.54
1.10
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
25
359
0.68
1.08
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
33
2.14
1.06
1.9
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
166
1861
0.84
1.05
4.7
5.6
%
2.6
2.7
0.19
149
1739
(4035726)
10
178
0.55
1.05
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
8
147
0.54
1.05
3.8
2.7
s
22.1
20.8
—
8
129
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
131
1499
0.83
1.05
4.8
4.5
umol/l
9.8
10.3
0.38
113
1393
(3013115) Eosinophils [#/volume] in Blood
182
2021
0.85
1.03
6.6
5.9
e9/l
0.2
0.2
0.46
155
1814
(3018010) Neutrophils/100 leukocytes in Blood
177
1968
0.85
1.01
4.4
5.3
%
54.9
55.3
0.25
159
1864
(3016502) Oxygen saturation in Arterial blood
9
161
0.55
0.99
12.0
13.6
%
96.3
96.9
—
9
150
(3038515) Glucose [Moles/volume] in Venous blood
0
29
0.00
0.98
0.0
2.0
—
6.3
—
0
29
(3021960) Folate [Moles/volume] in Serum or Plasma
68
554
1.26
0.98
1.3
1.3
nmol/l
18.3
19.3
0.27
58
483
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.7
—
10.9
—
0
23
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
31
0.00
0.96
0.0
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
32
0.00
0.95
0.0
1.1
—
1.1
—
0
14
(3029396) Erythrocyte agglutination [Presence] in Blood
0
32
0.00
0.95
0.0
3.0
—
—
—
0
0
(3039000) Anion gap in Blood
0
32
0.00
0.95
0.0
18.5
—
11.7
—
0
24
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
37
485
0.74
0.95
2.1
2.4
e6/l
9.7
5.3
0.51
19
235
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
279
0.67
0.93
1.4
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
176
1943
0.86
0.90
5.0
5.7
e9/l
0.5
0.5
0.11
147
1725
(3002385) Erythrocyte distribution width [Ratio]
392
3748
1.18
0.90
10.3
10.2
%
13.1
13.1
0.13
377
3661
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
169
0.58
0.89
2.2
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
128
0.54
0.89
1.0
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
177
1951
0.86
0.88
5.0
5.7
e9/l
0.0
0.0
0.12
145
1735
(40768443) Skin Pathology biopsy report
17
111
1.55
0.88
1.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
33
434
0.74
0.88
1.8
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
274
0.68
0.86
1.4
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
77
908
0.82
0.85
2.4
2.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
66
790
0.81
0.84
2.2
2.7
ug/g
102.4
111.7
0.05
44
609
(3002030) Lymphocytes/100 leukocytes in Blood
182
1995
0.87
0.84
4.5
5.5
%
31.6
31.0
0.39
165
1891
(3030467) Casts [#/volume] in Urine by Automated count
75
884
0.82
0.82
2.4
2.7
e6/l
0.2
0.2
0.15
53
643
(3000850) Epithelial cells [#/volume] in Urine
55
668
0.80
0.80
2.1
2.3
e6/l
11.0
9.2
0.25
46
589
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
24
0.00
0.79
0.0
1.0
—
96.4
—
0
11
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
97
0.51
0.78
2.8
1.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
124
0.56
0.78
4.0
3.1
%
149.9
161.8
—
7
118
(3000492) Spirometry study
32
413
0.76
0.76
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
251
2678
0.88
0.75
3.1
3.3
mm/h
7.6
7.6
0.02
219
2466
(3022096) Basophils/100 leukocytes in Blood
162
1777
0.87
0.74
4.7
5.8
%
0.6
0.6
0.15
145
1669
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
136
0.58
0.74
3.9
2.8
%
97.5
93.9
—
8
129
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
117
1037
1.16
0.73
1.6
1.5
pmol/l
87.0
97.5
1.62
64
574
(4034850)
6
108
0.55
0.73
5.8
6.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
99
867
1.17
0.72
6.0
5.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
68
1.63
0.72
1.2
2.5
—
—
—
0
0
(44813793)
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
28
363
0.76
0.70
1.6
2.2
%
22.6
24.7
0.35
23
322
(3019198) Lymphocytes [#/volume] in Blood
192
2069
0.89
0.65
4.8
5.6
e9/l
2.0
2.0
0.38
164
1870
(3017143) Hepatitis C virus Ab [Presence] in Serum
82
937
0.85
0.65
1.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
127
0.62
0.64
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
234
1.30
0.64
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
130
0.61
0.64
1.0
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
386
3724
1.14
0.63
7.3
7.9
mmol/l
139.7
139.4
1.95
362
3578
(3026782) Osmolality of Urine
53
627
0.83
0.62
2.2
2.4
mosm/kgh2o
556.8
587.7
0.39
39
545
(3002256) Pathology report gross observation
42
344
1.24
0.62
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
33
410
0.79
0.61
1.5
2.1
g/l
2.6
2.6
0.03
26
372
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.2
—
442.7
—
0
20
(3035933) Granulocytes/100 leukocytes in Blood
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
21
0.00
0.60
0.0
2.6
—
12.0
—
0
21
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
157
1.35
0.60
1.0
1.3
—
—
—
0
0
(4024509)
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
162
0.67
0.59
4.5
8.4
mmol/l
25.9
24.3
0.65
11
162
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
23
0.00
0.58
0.0
1.2
—
105.0
—
0
10
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
35
1.72
0.58
2.0
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
329
0.78
0.57
1.2
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
36
1.67
0.57
1.0
1.9
g/l
0.0
0.0
—
6
36
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
36
1.67
0.57
1.0
1.9
g/l
0.0
0.0
—
6
36
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
88
0.56
0.56
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
88
0.56
0.56
13.0
17.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
171
0.69
0.55
1.3
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
33
404
0.80
0.55
2.1
3.3
ug/l
1.0
1.5
1.31
25
370
(3014576) Chloride [Moles/volume] in Serum or Plasma
19
250
0.75
0.55
8.6
8.5
mmol/l
103.5
105.0
0.45
19
244
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
125
0.63
0.55
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
435
0.81
0.54
1.5
2.6
ng/l
15.6
961.8
1.38
13
191
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
187
1.30
0.53
3.3
2.4
mmol/l
1.2
1.2
0.02
18
161
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.54
0.53
1.0
1.9
g/l
0.0
0.0
—
6
39
(3013826) Glucose [Moles/volume] in Serum or Plasma
175
1874
0.90
0.52
3.1
4.3
mmol/l
6.0
6.1
0.57
160
1623
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
136
0.66
0.52
1.1
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
135
1.35
0.51
2.1
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
41
1.47
0.50
1.0
1.8
g/l
0.0
0.8
—
6
41
(40761536) Microorganisms panel - Urine sediment
36
431
0.82
0.50
2.8
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
346
3339
1.11
0.50
3.2
2.5
mmol/l
5.6
5.5
0.70
314
3090
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
33
272
1.23
0.48
3.5
3.5
pmol/l
4.9
4.8
0.35
27
241
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
47
1.50
0.47
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
119
1092
1.12
0.46
3.8
5.8
mmol/l
1.2
1.2
0.63
104
990
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
82
0.61
0.46
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
69
1.46
0.44
3.2
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
110
1194
0.90
0.42
1.4
1.4
g/l
2.2
2.0
0.88
52
765
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
1.4
—
0
15
(3024932) HLA-DR beta [Type]
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
30
251
1.21
0.40
2.4
2.2
—
20.7
—
0
19
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.1
—
106.2
—
0
18
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.1
—
3.8
—
0
18
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
54.0
—
0
19
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
342
3519
0.92
0.39
6.7
6.9
ml/min/173m2
105.9
105.2
0.23
229
2666
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
275
2854
0.92
0.39
3.2
2.5
u/l
39.2
30.1
1.22
253
2737
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
33
386
0.85
0.38
2.8
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
576
0.87
0.38
1.3
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
246
0.81
0.38
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1379
0.91
0.37
1.5
1.4
u/ml
1.1
1.8
0.65
26
358
(3020682) Albumin/Creatinine [Ratio] in Urine
44
501
0.87
0.37
3.4
4.7
mg/mmol
4.8
17.3
2.37
23
366
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.40
0.35
1.0
1.8
g/l
11.1
9.8
—
6
43
(40761535) Cells panel - Urine sediment
15
189
0.79
0.35
2.9
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
42
477
0.87
0.34
2.4
3.9
mg/l
46.7
110.9
1.37
21
349
(3023103) Potassium [Moles/volume] in Serum or Plasma
382
3734
1.08
0.34
7.4
7.9
mmol/l
3.8
3.9
5.13
358
3570
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
45
1.34
0.34
1.0
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
45
1.34
0.34
1.0
1.8
g/l
4.3
3.6
—
6
38
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
86
0.69
0.33
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
238
1.19
0.33
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
74
1.36
0.32
1.1
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
174
0.80
0.30
1.8
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
128
1217
1.07
0.24
3.5
6.3
mmol/l
1.2
1.2
0.29
101
1028
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
77
1.17
0.24
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
169
0.82
0.24
1.1
1.4
u/ml
145.0
197.8
—
8
93
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
169
0.82
0.24
1.0
1.1
u/ml
11.0
9.8
—
9
100
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
115
1.22
0.23
1.2
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
306
0.88
0.23
1.1
1.1
—
120.7
—
0
7
(3039443) Prostate specific Ag panel - Serum or Plasma
5
38
1.32
0.23
1.4
1.5
—
—
—
0
0
(4094501)
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(4027681)
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
42
1.19
0.21
1.8
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
5.8
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
6.3
—
0
10
(4038314)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
10
0.00
0.21
0.0
1.3
—
543.8
—
0
10
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
3.4
—
23.6
—
0
12
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
12
145
0.82
0.21
1.5
2.2
u/ml
28.6
24.9
0.23
12
140
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
3.0
1.9
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.1
—
2.7
—
0
14
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
200
1940
1.05
0.19
2.8
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
52
1.16
0.19
1.5
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
258
0.89
0.18
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
578
0.93
0.18
1.3
1.2
u/ml
23.3
8.4
0.42
15
234
(3020891) Body temperature
5
69
0.72
0.17
12.4
5.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
410
0.92
0.15
1.1
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
78
1.16
0.15
1.1
1.3
—
1.6
—
0
11
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
78
1.16
0.15
1.3
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
161
0.87
0.15
1.0
1.1
u/ml
0.2
1.9
—
9
72
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
251
2460
1.04
0.15
5.5
5.9
u/l
78.0
70.3
2.10
219
2299
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
82
1.10
0.15
1.0
1.3
—
7.5
—
0
7
(4010399)
16
180
0.89
0.13
1.4
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
32
296
1.09
0.13
3.3
2.5
u/l
26.9
30.2
0.76
27
238
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
330
3256
1.04
0.13
2.8
2.5
mmol/l
1.3
1.2
1.54
305
3083
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
106
0.85
0.13
1.1
1.1
—
3.8
—
0
8
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
447
0.93
0.13
1.2
1.2
iu/ml
108.7
127.3
0.13
12
164
(3014111) Lactate [Moles/volume] in Serum or Plasma
18
200
0.90
0.12
5.3
8.6
mmol/l
1.3
1.3
0.11
18
189
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
104
1.16
0.12
1.1
1.3
—
56.8
—
0
10
(3044290) Cell count panel - Cerebral spinal fluid
10
85
1.18
0.12
1.4
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
114
1.14
0.12
1.1
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
422
4253
0.96
0.11
7.5
6.8
u/l
26.8
25.6
0.59
398
4106
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
34
363
0.93
0.11
3.3
2.8
umol/l
5.5
6.8
0.33
26
295
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
66
688
0.95
0.11
1.7
2.0
u/l
162.7
272.4
0.48
54
663
(3000991) Gas panel - Venous blood
18
198
0.91
0.11
6.1
10.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
115
0.87
0.10
1.0
1.1
u/ml
0.6
9.5
—
5
52
(3017181) Myelocytes/100 leukocytes in Blood
25
269
0.93
0.10
6.4
4.3
%
0.6
0.8
—
8
68
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
135
0.89
0.10
1.2
1.1
u/ml
0.5
5.9
—
5
53
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
289
0.93
0.09
5.4
4.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
1.2
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
194
1.09
0.09
1.2
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
97
1.14
0.09
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
175
0.91
0.08
1.1
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
120
1227
0.97
0.08
3.9
5.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
66
1.06
0.08
1.1
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
256
0.93
0.08
4.3
3.9
%
0.3
0.3
—
7
49
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
73
0.82
0.07
1.8
3.1
%
50.3
50.7
—
6
73
(3028026) IgM [Mass/volume] in Serum or Plasma
22
235
0.93
0.07
1.3
1.8
g/l
1.1
1.1
0.03
17
216
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
8
94
0.85
0.06
1.3
3.1
ng/l
27.8
57.9
—
8
82
(1002224) Polysomnography panel
14
129
1.09
0.05
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
48
466
1.03
0.05
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
357
1.04
0.05
1.3
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
91
1.10
0.04
1.0
1.2
mmol/l
3.6
3.6
—
10
85
(3019225) pH of Specimen
23
241
0.95
0.04
2.0
3.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
190
0.95
0.04
1.1
1.1
u/ml
6.3
1.4
—
8
75
(3025159) Blasts/100 leukocytes in Blood
26
250
1.04
0.03
6.2
4.5
%
0.0
0.1
—
8
52
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
239
0.96
0.02
1.8
2.2
ug/l
0.4
0.7
2.50
11
119
(3021440) Promyelocytes/100 leukocytes in Blood
25
259
0.96
0.02
6.4
4.4
%
0.0
0.1
—
8
61
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
93
1.08
0.02
2.5
4.2
%
57.4
54.0
—
10
93
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
93
1.08
0.02
2.5
4.1
e9/l
4.2
3.5
—
10
93
(3037522) Nuclear Ab [Titer] in Serum
56
552
1.02
0.01
1.3
1.4
titre
218.2
561.2
3.44
11
101
(3013512) EKG study
62
628
0.99
0.01
2.3
2.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
593
1.01
0.01
1.4
1.2
iu/ml
15.5
16.9
0.12
15
166
(3003327) Ova and parasites identified in Stool by Light microscopy
20
196
1.02
0.00
1.4
1.7
—
—
—
0
0
(3012544) pH of Venous blood
21
214
0.98
0.00
2.6
5.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
10
102
0.98
0.00
1.2
1.4
mg/l
435.8
484.8
—
10
97
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
307
1.01
0.00
2.5
2.4
%
30.8
32.3
0.25
21
228
(3002032) Base excess in Venous blood by calculation
21
208
1.01
0.00
2.5
5.0
mmol/l
2.7
1.2
0.75
16
157
(3022313) Gas panel - Capillary blood
11
111
0.99
0.00
2.5
4.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
88
879
1.00
0.00
2.1
2.8
kg/l
1.0
1.0
—
5
120
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
65
0.92
0.00
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
65
0.92
0.00
1.2
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
22.9
—
0
7
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
67
0.89
0.00
1.0
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.7
—
1.2
—
0
6
(3020393) Adenovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
4.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
4.8
—
22.9
—
0
6
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
9
0.00
0.00
0.0
2.4
—
2.6
—
0
9
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
71
0.99
0.00
2.4
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.4
—
8.4
—
0
5
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.4
—
37.0
—
0
8
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1.3
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
3.5
—
0.7
—
0
6
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
4.8
—
0
5
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
181.0
—
0
9
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.5
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_GENDER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have F5_GENDER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: F5_GENDER – Gender identity disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data